Rapid Micro Biosystems (RPID) Non Operating Income (2020 - 2026)
Rapid Micro Biosystems (RPID) reported Non Operating Income of -$415000.0 for Q1 2026, down 202.47% on a YoY basis from $405000.0 in Q1 2025, and down 52.57% sequentially from -$272000.0 in Q4 2025.
Rapid Micro Biosystems (RPID) Non Operating Income (2020 - 2026) Analysis & Trends
Rapid Micro Biosystems (RPID) has 7 years of Non Operating Income data on file, last reported at -$415000.0 in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income fell 202.47% year-over-year to -$415000.0; the trailing twelve-month figure through Mar 2026 stood at -$511000.0 (down 120.42% YoY), and the FY2025 full-year result was $309000.0, down 89.88% from the prior year.
- Non Operating Income eased to -$415000.0 in Q1 2026, from -$272000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $1.1 million in Q4 2023 to a low of -$415000.0 in Q1 2026.
- A 5-year average of $530705.9 and a median of $554000.0 in 2022 frame the typical range for Non Operating Income.
- Across the five-year window, Non Operating Income surged 5566.67% in 2022 and tumbled 202.47% in 2026, its largest moves.
- Tracing RPID's Non Operating Income over 5 years: stood at $820000.0 in 2022, then jumped by 35.0% to $1.1 million in 2023, then tumbled by 49.95% to $554000.0 in 2024, then tumbled by 149.1% to -$272000.0 in 2025, then tumbled by 52.57% to -$415000.0 in 2026.
- Business Quant data shows RPID's Non Operating Income at -$415000.0 in Q1 2026, -$272000.0 in Q4 2025, and -$125000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 62.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -18.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Rapid Micro Biosystems | 90.41 Mn | 80.98 Mn | 371,000.00 | -415,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -415,000.00 |
| Dec 31, 2025 | -272,000.00 |
| Sep 30, 2025 | -125,000.00 |
| Jun 30, 2025 | 301,000.00 |
| Mar 31, 2025 | 405,000.00 |
| Dec 31, 2024 | 554,000.00 |
| Sep 30, 2024 | 729,000.00 |
| Jun 30, 2024 | 815,000.00 |
| Mar 31, 2024 | 983,000.00 |
| Dec 31, 2023 | 1.11 Mn |
| Sep 30, 2023 | 1.07 Mn |
| Jun 30, 2023 | 1.04 Mn |
| Mar 31, 2023 | 992,000.00 |
| Dec 31, 2022 | 820,000.00 |
| Sep 30, 2022 | 554,000.00 |
| Jun 30, 2022 | 371,000.00 |
| Mar 31, 2022 | 92,000.00 |
| Dec 31, 2021 | -15,000.00 |
| Sep 30, 2021 | -12.84 Mn |
| Jun 30, 2021 | -951,000.00 |